FDA clears new drug-eluting envelope for implantable cardiac devices—CEO sees it as ‘tip of the iceberg’ Posted on June 20th, 2024 by Betsy Stovsky Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: ABBOTT RECEIVES CE MARK FOR AVEIR™ DR, THE WORLD’S FIRST DUAL CHAMBER LEADLESS PACEMAKER SYSTEMNext: Biotronik receives CE mark for Amvia Sky and Edge devices
ABBOTT RECEIVES CE MARK FOR AVEIR™ DR, THE WORLD’S FIRST DUAL CHAMBER LEADLESS PACEMAKER SYSTEM Posted on June 6th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Abbott receives CE mark for Aveir dual chamber leadless pacemaker systemNext: FDA clears new drug-eluting envelope for implantable cardiac devices—CEO sees it as ‘tip of the iceberg’
Abbott receives CE mark for Aveir dual chamber leadless pacemaker system Posted on June 6th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: CIED Infection Quality Initiative Demonstration Project (RECTIFY)Next: ABBOTT RECEIVES CE MARK FOR AVEIR™ DR, THE WORLD’S FIRST DUAL CHAMBER LEADLESS PACEMAKER SYSTEM